Key facts
- This page summarizes Troy A. Ignelzi's Form 4 filing for Karuna Therapeutics, Inc..
- 6 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 24 Aug 2023, 16:49.
Troy A. Ignelzi - 22 Aug 2023 Form 4 Insider Report for Karuna Therapeutics, Inc.
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- N/A
- Reported as of
- 22 Aug 2023
- Net transaction value
- -$248,883
- SEC form
- 4
- Accepted by SEC
- 24 Aug 2023, 16:49:56 UTC
- Prior SEC filing
- 25 May 2023
- Next SEC filing
- 20 May 2024
- Source filing
- View source filing
- Reporting owner signature
- /s/ Troy Ignelzi
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Troy A. Ignelzi filed Form 4 for Karuna Therapeutics, Inc. on 24 Aug 2023.
Change
- Previous filing in this sequence was filed on 25 May 2023.
- Current net transaction value: -$248,883.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
KRTX
transaction
Common Stock
Options Exercise
- Transaction value
- $13,800
- Shares
- +1,500
- Change %
- +4.9%
- Price
- $9.20*
- Shares after
- 31,987
- Date
- 22 Aug 2023
- Ownership
- Direct
- Footnotes
- F1
KRTX
transaction
Common Stock
Sale
- Transaction value
- $13,891
- Shares
- -80
- Change %
- -0.25%
- Price
- $173.64
- Shares after
- 31,907
- Date
- 22 Aug 2023
- Ownership
- Direct
- Footnotes
- F1, F2
KRTX
transaction
Common Stock
Sale
- Transaction value
- $149,522
- Shares
- -855
- Change %
- -2.7%
- Price
- $174.88
- Shares after
- 31,052
- Date
- 22 Aug 2023
- Ownership
- Direct
- Footnotes
- F1, F3
KRTX
transaction
Common Stock
Sale
- Transaction value
- $88,673
- Shares
- -505
- Change %
- -1.6%
- Price
- $175.59
- Shares after
- 30,547
- Date
- 22 Aug 2023
- Ownership
- Direct
- Footnotes
- F1, F4
KRTX
transaction
Common Stock
Sale
- Transaction value
- $10,596
- Shares
- -60
- Change %
- -0.2%
- Price
- $176.60
- Shares after
- 30,487
- Date
- 22 Aug 2023
- Ownership
- Direct
- Footnotes
- F1, F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
KRTX
transaction
Derivative
Option (right to buy)
Options Exercise
- Transaction value
- $0
- Shares
- -1,500
- Change %
- -1.6%
- Price
- $0.000000
- Shares after
- 93,226
- Date
- 22 Aug 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,500
- Exercise price
- $9.20
- Footnotes
- F1, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 6 footnotes
Footnote F1
The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 12, 2022.
Footnote F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.31 to $174.16, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in footnotes (2) through (5) to this Form 4.
Footnote F3
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $174.32 to $175.31, inclusive.
Footnote F4
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.32 to $176.30, inclusive.
Footnote F5
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $176.59 to $176.61, inclusive.
Footnote F6
This option vested as to 25% of the shares on the first anniversary of the vesting commencement date of March 1, 2019, with additional vesting as to 12.5% of the shares underlying the option award on each six month period thereafter.